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Introduction
Published drug information is widely available 
for terrestrial conditions.  However, information 
on dosing, administration, drug interactions, 
stability, and side effects is scant as it relates to 
use in Space Medicine.  Multinational crews on 
board the International Space Station present 
additional challenges for drug information 
because medication nomenclature, information 
available for the drug as well as the intended 
use for the drug, is not standard across 
countries.  There are unique needs for drug 
information and how the information is managed 
in Space Medicine. 
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Methods
• A review was conducted of the drug 
information requests submitted to the 
Johnson Space Center Pharmacy.
• From January 2003 to March 2009; 108 
detailed drug information requests 
catalogued by the JSC Pharmacy Team.
• Requests from Space Medicine and 
Occupational Medicine practitioners, 
astronaut crewmembers and researchers.  
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Results
The wide range of information was reviewed.  
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Topic
% of 
requests
General drug information 40.74%
Drug information support - flight or dive physicals 29.63%
Stability of medications 4.63%
Identification of Non-U.S. medications 4.63%
Drug-Drug Interactions with commonly used medications for 
reduced gravity flights as well as space flight 3.70%
Interactions with medications in medical kit 3.70%
Side effect profiles of commonly used medications for reduced 
gravity flights as well as space flight 2.78%
Use of herbal supplements and interactions with labs/other drugs 1.85%
Drug information in support of a medication improving a space 
physiology change 1.85%
Interactions with other countermeasures 1.85%
Antidote questions – space flight specific 0.93%
Alternative therapeutic suggestions for medications in med kits 0.93%
Drug-Drug Interactions of contents in the landing kit 0.93%
Pharmacologic/pharmaceutic considerations in space flight 0.93%
• Due to the information needs for the 
medications in the on-board medical kits, 
the Drug Monograph Project was created.
• Drug monographs are written for clinician 
use and are to be used as an aid from the 
ground.
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What is a Drug Monograph?
• A statement that specifies the kinds and 
amounts of ingredients a drug or class of 
drugs may contain, the directions for the 
drug's use, the conditions in which it may 
be used, and the contraindications to its 
use (Mosby’s Medical Dictionary, 2009). 
• A Space Medicine drug monograph is 
tailored to the population and health status 
of space flight crewmembers.
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Contents of the Space Medicine Monograph
• Brand Name
• Drug Category
• Rx/OTC
• ISS Dosage Form
• Description / Major Actions
• Indications
• Contraindications / Precautions
• Allergy Alert
• Effects on Cognition and Performance
• Notable Adverse Reactions
• Antidote Availability
• Drug-Drug Interactions
• CYP450 Interactions
• Drug-Food/Herbal Interactions
• IV Compatibility
• Terrestrial Dosage Administration
• Microgravity Dosage Information
• Special Instructions
• Storage Instructions
• Earth Shelf Life
• Microgravity Stability Information
• Analog
Differences from Terrestrial 
Drug Monograph
• Indications: 
– Acute indications listed
• Contraindications/Precautions: 
– No chronic disease related information
– Concurrent drug therapy only as it applies to 
other contents of kit
– No pediatric information
– No pregnancy information
• Effects on cognitive performance:
– Highlighted due to nature of work
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Differences from Terrestrial 
Drug Monograph
• Drug-Drug Interactions:
– Information specific to contents in the kit
• CYP450 Interactions:
– Specific interactions with traditional and 
alternative medicines highlighted
• Microgravity dosing:
– Provided if available from research literature
• Special instructions:
– Special considerations or instructions for use 
of medication in microgravity
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Differences from Terrestrial 
Drug Monograph
• Microgravity stability information:
– Provided as information is published from the 
stability studies
• Analog: 
– Russian medical kit on orbit
– Review of contents and match to U.S. drug
– If an analog is available in the Russian kit, 
information is listed in this section
– Provides options for the crew surgeon
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• Screen shots of monographs (requires 
graphics assistance)
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Information Management
• References used include primary and 
tertiary sources
– PubMed review of literature
– Traditional pharmacy drug information 
references
– International drug information reference -
Martindale
• Complete review of contents occur 
annually
– Updated as needed for new precautions, 
dosing, stability
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• Extramural reviewers
– Pharmacists in clinical practice review 
contents and provide input
Information Management
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Future Considerations for 
Drug Information
• U.S. Space Program
– Drug utilization reviews of medication usage 
could provide insight into microgravity dosing
– Rotation of International Partners could mean 
more Non-U.S. medications, require drug 
information and identification
• Commercial space flight
– Population changes and more medication use 
will require greater use of drug information
– Multinational space flight participants require 
review of medication with existing 
countermeasures
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